NZ biotech chooses Australia for IPO
Wednesday, 16 October, 2013 - 12:23
Perth based stockbroking firm Patersons Securities is punting on investors’ emerging appetite for biotech stocks, agreeing to underwrite New Zealand biopharmaceutical company Innate Immunotherapeutics’s $16.5 million initial public offering.